Table 2 Potentially preventable fraction of HPV-associated cancers in Colombia with currently available HPV vaccines
From: Prevention and control of HPV infection and HPV-related cancers in Colombia- a meeting report
Anatomic Site | No. | HPV DNA+ | HPV DNA+ Bivalent (2-valent) or quadrivalent (4-valent) Vaccines | HPVDNA + Nonavalent (9-valent) Vaccine |
|---|---|---|---|---|
ANUS | 39 | 94.9% | 81.1% | 100.0% |
CERVIX | 841 | 78.4% | 67.5% | 87.7% |
HEAD & NECK | 192 | 26.0% | 80.0% | 88.0% |
PENIS | 54 | 50.0% | 70.4% | 85.2% |
VAGINA | 29 | 72.4% | 47.6% | 85.7% |
VULVA | 48 | 60% | 79% | 86% |